Old Web
English
Sign In
Acemap
>
Paper
>
Characterization of Residual CLL Following Long-Term Bruton Tyrosine Kinase Inhibitor Therapy
Characterization of Residual CLL Following Long-Term Bruton Tyrosine Kinase Inhibitor Therapy
2021
Shanmugapriya Thangavadivel
Alexander Pan
Xi Chen
Chen Song
Claire Snyder
Kerry A. Rogers
Seema A. Bhat
Adam Kittai
Bradley W. Blaser
James S. Blachly
Pearlly S. Yan
John C. Byrd
Jennifer A. Woyach
Keywords:
Chemistry
Cancer research
Bruton's tyrosine kinase
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]